Recruiting studies: Factor Viii Deficiency Congenital

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Prevalence of Synovitis in Patients With Haemophilia A
Phase N/A · 1 location(s) · University Hospital, Bonn · NCT06352216 Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Ef
Phase 4 · 29 location(s) · Swedish Orphan Biovitrum · NCT06940830 Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
Phase 4 · 13 location(s) · Sanofi · NCT06941870 Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
Phase 4 · 16 location(s) · Octapharma · NCT05936580 Embolization in Hereditary Coagulopathies
NA · 1 location(s) · University of Sao Paulo General Hospital · NCT05629130 ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Phase N/A · 71 location(s) · American Thrombosis and Hemostasis Network · NCT04398628 A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI
Phase N/A · 1 location(s) · Haemophilia Centre Rhine Main · NCT02207894 A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Hea
Phase 1 · 10 location(s) · Equilibra Bioscience LLC · NCT06349473 Safety of KN057 Prophylaxis in Patients With Haemophilia A or B
Phase 3 · 1 location(s) · Suzhou Alphamab Co., Ltd. · NCT07545395 Study of Surgical Practices in Hemophilia A Patients Treated With Efanesoctocog Alfa (Altuvoct®)
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT07723560 An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine Esperoct
Phase N/A · 1 location(s) · Novo Nordisk A/S · NCT05621746 An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic
Phase 1/Phase 2 · 9 location(s) · Shanghai RAAS Blood Products Co., Ltd. · NCT07644832 A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
Phase 3 · 152 location(s) · Novo Nordisk A/S · NCT05685238 Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Phase 4 · 18 location(s) · Octapharma · NCT05935358 Hemlibra in Mild Hemophilia A
Phase 4 · 1 location(s) · Indiana Hemophilia &Thrombosis Center, Inc. · NCT04567511 Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.
Phase 3 · 1 location(s) · Sinocelltech Ltd. · NCT07437404 A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Phase 1 · 33 location(s) · Novo Nordisk A/S · NCT07220564 A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in Taiwan
Phase N/A · 10 location(s) · Sanofi · NCT06684314 Long-term Anticoagulation in a Patient With Severe Hemophilia A
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07314983 Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa
Phase 3 · 21 location(s) · Swedish Orphan Biovitrum · NCT06716814 Hemophilia A Research Program
Phase N/A · 1 location(s) · University of Washington · NCT07414511 SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
Phase 3 · 2 location(s) · Emory University · NCT04563520 Multidimensional Assessment of Chronic Pain in Severe Haemophilia A
Phase N/A · 1 location(s) · Investigación en Hemofilia y Fisioterapia · NCT07096349 Treatment of Hemophilia A Patients With FVIII Inhibitors
Phase N/A · 2 location(s) · Emory University · NCT04023019 Longitudinal Cohort of Thrombosis and Hemostasis Diseases
Phase N/A · 5 location(s) · Peking University People's Hospital · NCT06727669 Pharmacokinetic-guided Dosing of Emicizumab
Phase 4 · 8 location(s) · Kathelijn Fischer · NCT06320626 Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A P
Phase N/A · 59 location(s) · Octapharma · NCT03695978 The European Paediatric Network for Haemophilia Management ( PedNet Registry)
Phase N/A · 39 location(s) · PedNet Haemophilia Research Foundation · NCT02979119

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.